Drug intelligence / Profile preview

IR-775

Development stage
Preclinical
Modality
Small Molecules
Administration
Intravenous, Topical
01

Overview

IR-775 is a hydrophobic near-infrared heptamethine cyanine small-molecule dye used primarily as an experimental phototheranostic agent rather than an approved medicine. In the published literature, it functions as a photosensitizer and photothermal transducer for fluorescence imaging, photodynamic therapy, and photothermal therapy, often after encapsulation into liposomes, polymeric nanoparticles, cyclodextrin nanocarriers, or other delivery systems to improve solubility, tumor delivery, and cellular uptake. Upon near-infrared light irradiation, IR-775 generates reactive oxygen species and heat, enabling image-guided tumor ablation in preclinical cancer models; it has also been used as a fluorescent tracer cargo in drug-delivery studies. The available evidence indicates preclinical development only, with no clear evidence from the provided sources of an approved developer-led pharmaceutical product or commercial brand.

Other names
IR-775 chlorideIR775 chlorideIR 775 chlorideIR775 cyanineIR-775 cyanineIR 775 cyanineIR775 dyeIR-775 dyeIR 775 dyeheptamethine cyanine dye IR775near-infrared dye IR-775

Beyond the preview

Go deeper on IR-775.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IR-775.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call